Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 583.51-91.805.4623.93404.51

What is the latest EBIT Growth ratio of BALAXI PHARMACEUTICALS ?

The latest EBIT Growth ratio of BALAXI PHARMACEUTICALS is 583.51 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025583.51
Mar2024-91.80
Mar20235.46
Mar202223.93
Mar2021404.51

How is EBIT Growth of BALAXI PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 583.51
Positive
Mar2024 -91.8
Negative
Mar2023 5.46
-77.18
Mar2022 23.93
-94.08
Mar2021 404.51 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹91.0 Cr -6.6% -17.7% -74.4% Stock Analytics
ADANI ENTERPRISES ₹235,637.0 Cr -5.4% -16.5% -17.7% Stock Analytics
REDINGTON ₹15,698.0 Cr -7.6% -16.3% -15.5% Stock Analytics
HONASA CONSUMER ₹9,700.9 Cr 3% -2.5% 33.1% Stock Analytics
MMTC ₹8,277.0 Cr -7.7% -10.5% 3.9% Stock Analytics
LLOYDS ENTERPRISES ₹6,498.5 Cr -6% -21.2% 11.2% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-6.6%

-17.7%

-74.4%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses